Filter News
Area of Research
- (-) Computational Biology (2)
- (-) Functional Materials for Energy (2)
- Advanced Manufacturing (10)
- Biological Systems (1)
- Biology and Environment (68)
- Building Technologies (2)
- Clean Energy (166)
- Computational Engineering (3)
- Computer Science (11)
- Electricity and Smart Grid (3)
- Energy Sciences (2)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (32)
- Fusion Energy (11)
- Isotope Development and Production (1)
- Isotopes (9)
- Materials (81)
- Materials for Computing (12)
- Mathematics (1)
- National Security (26)
- Neutron Science (30)
- Nuclear Science and Technology (39)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (9)
- Sensors and Controls (1)
- Supercomputing (68)
News Type
News Topics
- (-) Biomedical (2)
- (-) Energy Storage (2)
- (-) Grid (1)
- (-) Machine Learning (1)
- (-) Sustainable Energy (1)
- Artificial Intelligence (2)
- Biology (2)
- Buildings (1)
- Computer Science (1)
- Coronavirus (1)
- Decarbonization (1)
- Environment (1)
- Frontier (1)
- High-Performance Computing (3)
- Materials (2)
- Materials Science (1)
- Neutron Science (1)
- Simulation (1)
- Summit (1)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
Materials scientist and chemist Nancy Dudney has been elected to the National Academy of Engineering for her groundbreaking research and development of high-performance solid-state rechargeable batteries.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.